TELA Bio, Inc. (TELA) Revenue History
Annual and quarterly revenue from 2017 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TELA Revenue Growth
Revenue Breakdown
TELA's revenue distribution by segment and geography
By Geography
TELA Revenue Analysis (2017–2024)
As of May 8, 2026, TELA Bio, Inc. (TELA) generated trailing twelve-month (TTM) revenue of $77.1 million, reflecting solid growth of +9.1% year-over-year. The most recent quarter (Q3 2025) recorded $20.7 million in revenue, up 2.4% sequentially.
Looking at the longer-term picture, TELA's 5-year compound annual growth rate (CAGR) stands at +35.0%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $69.3 million in 2024, representing a new all-time high.
When compared to Healthcare sector peers including XTNT (+16.9% YoY), ATRC (+15.0% YoY), and NVCR (+8.5% YoY), TELA has underperformed the peer group in terms of revenue growth. Compare TELA vs XTNT →
TELA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TELACurrent | $77M | +9.1% | +35.0% | -49.2% | |
 XTNT | $117M | +16.9% | +12.6% | -10.3% | |
 ATRC | $535M | +15.0% | +20.9% | -0.6% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 OSUR | $115M | -47.3% | -7.7% | -59.2% | |
 MMSI | $1.5B | +11.2% | +9.5% | 12.2% |
TELA Historical Revenue Data (2017–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $69.3M | +18.6% | $46.5M | 67.1% | $-34,115,000 | -49.2% |
| 2023 | $58.5M | +41.1% | $40.1M | 68.6% | $-44,075,000 | -75.4% |
| 2022 | $41.4M | +40.6% | $27.0M | 65.3% | $-39,007,000 | -94.2% |
| 2021 | $29.5M | +61.8% | $18.8M | 63.9% | $-29,451,000 | -100.0% |
| 2020 | $18.2M | +17.9% | $11.2M | 61.7% | $-25,275,000 | -138.8% |
| 2019 | $15.4M | +86.7% | $9.3M | 60.0% | $-19,162,000 | -124.1% |
| 2018 | $8.3M | +94.9% | $2.9M | 35.6% | $-17,782,000 | -214.9% |
| 2017 | $4.2M | - | $2.5M | 59.6% | $-16,924,000 | -398.7% |
See TELA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TELA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TELA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTELA — Frequently Asked Questions
Quick answers to the most common questions about buying TELA stock.
Is TELA's revenue growth accelerating or slowing?
TELA maintains +9.1% revenue growth, in line with its 5-year CAGR of +35.0%. TTM revenue stands at $77M. Growth rate remains consistent with historical average.
What is TELA's long-term revenue growth rate?
TELA Bio, Inc.'s 5-year revenue CAGR of +35.0% reflects the sustained expansion pattern. Current YoY growth of +9.1% is near this long-term average.
How is TELA's revenue distributed by segment?
TELA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2024 are available for download. Segment mix reveals concentration and diversification trends.